￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the best time to take Regorafenib (Belvango) and daily medication precautions

2026-02-01 22:25:32

Check Details
A must-read guide for patients with contraindications and precautions for using Pazopanib (Victor)

2026-02-01 22:25:32

Check Details
Opicapone original manufacturer information and drug background introduction

2026-02-01 22:25:32

Check Details
Fenelidone (Keshenda) toxicity intensity analysis and safe dose reference

2026-02-01 22:25:32

Check Details
Analysis of the range of diseases and indications that rasagiline (Azilai) can treat

2026-02-01 22:25:32

Check Details
Introduction and R&D background of Trelagliptin produced by Takeda Pharmaceuticals in Japan

2026-02-01 22:25:32

Check Details
The official launch time and domestic approval progress of Inalise (Ihelai)

2026-02-01 22:25:32

Check Details
What diseases does Abatacept (Enrisu) mainly treat and its clinical scope of application?

2026-02-01 22:25:32

Check Details
A complete list of precautions and medication contraindications during the use of Lebolaysin (Davico)

2026-02-01 22:25:32

Check Details
Analysis of real patient use effects and clinical trial data of Mavakatai (Mefanto)

2026-02-01 22:25:32

Check Details
Possible side effects after discontinuation of tenofovir alafenamide fumarate tablets (Vemlidy)

2026-02-01 22:25:32

Check Details
The domestic selling price of vorasidenib-VORANIGO and the price difference with the imported version

2026-02-01 22:25:32

Check Details
Category
相关知识